• MYH7 Gene Mutation Analysis
  • Protein, Total, Random, Urine
  • Antimicrobial Susceptibility, AFB/Mycobacteria
  • Hydroxychloroquine, Serum
  • Thiopental, Urine
  • Phenosense Entry HIV Drug Resistance Assay
  • Glucose-6-Phosphate Dehydrogenase (G6PD)
  • Cytochrome P450 2E1 (CYP2E1) Genotyping
  • Influenza Virus Type A and B, Culture
  • Myelodysplastic Syndrome (MDS), Flow Cytometry, Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

LOINC
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.